Related Experiment Videos
Hot spots in Tcf4 for the interaction with beta-catenin
Marina Fasolini1, Xiaoqiu Wu, Maria Flocco
1Pharmacia Corporation Discovery Research Oncology, Department of Chemistry, Viale Pasteur 10, 20014 Nerviano, Italy.
The Journal of Biological Chemistry
|March 27, 2003
Summary
Beta-catenin and T-cell factor (Tcf) 4 interaction is key in Wnt signaling. Mutagenesis revealed specific Tcf4 residues critical for binding, offering targets for novel anti-cancer drug development.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- The Wnt signaling pathway is crucial in cellular processes.
- Beta-catenin/T-cell factor (Tcf) 4 interaction is a key target for anti-cancer drug development.
Purpose of the Study:
- To investigate the binding energetics of Tcf4 mutants with beta-catenin.
- To identify critical residues in the Tcf4-beta-catenin interface for drug development.
Main Methods:
- Performed Ala-scanning mutagenesis on Tcf4 residues.
- Utilized isothermal titration calorimetry to study binding energetics.
Main Results:
- Tcf4 binding to beta-catenin is highly cooperative.
- Mutations D16A, D11A, Leu41A, Val44A, and Leu48A significantly reduced binding constants.
- Mutations at Glu24 and Glu28 affected binding enthalpies but not binding constants significantly.
Conclusions:
- Identified specific Tcf4 residues that are critical for stable binding to beta-catenin.
- These findings provide insights for designing Tcf antagonists for cancer therapy.